- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
5
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
5 companies
Abbott India
Market Cap: ₹554.5b
Operates as a pharmaceutical company in India.
500488
₹26,245.50
7D
-3.1%
1Y
-17.8%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹508.2b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,899.60
7D
7.8%
1Y
3.6%
Sanofi India
Market Cap: ₹76.5b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,348.30
7D
3.1%
1Y
-36.0%
Hester Biosciences
Market Cap: ₹20.5b
Manufactures and trades in veterinary vaccines and health products in India and internationally.
524669
₹2,385.90
7D
-1.1%
1Y
18.2%
Shukra Pharmaceuticals
Market Cap: ₹19.1b
Manufactures and markets pharmaceutical products in India and internationally.
524632
₹44.11
7D
6.5%
1Y
92.9%